Achieve Life Sciences Statistics
Total Valuation
ACHV has a market cap or net worth of $775.88 million. The enterprise value is $603.53 million.
| Market Cap | 775.88M |
| Enterprise Value | 603.53M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHV has 102.90 million shares outstanding. The number of shares has increased by 82.32% in one year.
| Current Share Class | 102.90M |
| Shares Outstanding | 102.90M |
| Shares Change (YoY) | +82.32% |
| Shares Change (QoQ) | +75.17% |
| Owned by Insiders (%) | 2.31% |
| Owned by Institutions (%) | 60.28% |
| Float | 74.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 93.87 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.95
| Current Ratio | 0.95 |
| Quick Ratio | 0.95 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -58.63 |
Financial Efficiency
Return on equity (ROE) is -844.99% and return on invested capital (ROIC) is -140.36%.
| Return on Equity (ROE) | -844.99% |
| Return on Assets (ROA) | -29.21% |
| Return on Invested Capital (ROIC) | -140.36% |
| Return on Capital Employed (ROCE) | 807.40% |
| Weighted Average Cost of Capital (WACC) | 16.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.07M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +157.34% in the last 52 weeks. The beta is 2.25, so ACHV's price volatility has been higher than the market average.
| Beta (5Y) | 2.25 |
| 52-Week Price Change | +157.34% |
| 50-Day Moving Average | 6.99 |
| 200-Day Moving Average | 5.18 |
| Relative Strength Index (RSI) | 48.60 |
| Average Volume (20 Days) | 1,598,780 |
Short Selling Information
The latest short interest is 16.42 million, so 15.95% of the outstanding shares have been sold short.
| Short Interest | 16.42M |
| Short Previous Month | 16.27M |
| Short % of Shares Out | 15.95% |
| Short % of Float | 21.98% |
| Short Ratio (days to cover) | 13.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -58.28M |
| Pretax Income | -114.04M |
| Net Income | -114.04M |
| EBITDA | -58.05M |
| EBIT | -58.28M |
| Earnings Per Share (EPS) | -$1.81 |
Balance Sheet
The company has $187.30 million in cash and $14.95 million in debt, with a net cash position of $172.36 million or $1.67 per share.
| Cash & Cash Equivalents | 187.30M |
| Total Debt | 14.95M |
| Net Cash | 172.36M |
| Net Cash Per Share | $1.67 |
| Equity (Book Value) | -14.68M |
| Book Value Per Share | -0.14 |
| Working Capital | -9.36M |
Cash Flow
In the last 12 months, operating cash flow was -$47.02 million and capital expenditures -$19,000, giving a free cash flow of -$47.04 million.
| Operating Cash Flow | -47.02M |
| Capital Expenditures | -19,000 |
| Depreciation & Amortization | 225,000 |
| Net Borrowing | 5.00M |
| Free Cash Flow | -47.04M |
| FCF Per Share | -$0.46 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACHV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -82.32% |
| Shareholder Yield | -82.32% |
| Earnings Yield | -14.70% |
| FCF Yield | -6.06% |
Analyst Forecast
The average price target for ACHV is $13.83, which is 83.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.83 |
| Price Target Difference | 83.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 31, 2020. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jul 31, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |